Today: 11 June 2026
Browse Category

NYSE:UNH 3 January 2026 - 12 January 2026

Healthcare stocks face JPMorgan conference pressure as XLV slips and deal talk builds

Healthcare stocks face JPMorgan conference pressure as XLV slips and deal talk builds

U.S. healthcare stocks fell this week, with the XLV ETF down 0.5% to $157.31, even as the S&P 500 hit a record high. Two biotech firms, Eikon Therapeutics and Veradermics, filed for IPOs. Healthcare M&A value rose 56% in 2025 to $403 billion, despite fewer deals. Insmed reported preliminary 2025 ARIKAYCE sales of $433.8 million and set a 2026 revenue target of $450–470 million.
10 January 2026
···
UnitedHealth stock (UNH) hit by fresh Senate heat as nursing-home probe widens before earnings

UnitedHealth stock (UNH) hit by fresh Senate heat as nursing-home probe widens before earnings

UnitedHealth shares fell 0.8% to $343.98 Friday as senators widened their probe into the company’s nursing-home programs, citing unsatisfactory responses. Lawmakers warned they may escalate pressure if UnitedHealth does not cooperate. The company’s earnings call is set for Jan. 27. Investors are also awaiting the Jan. 13 consumer price index data.
10 January 2026
··
UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

U.S. House committees summoned UnitedHealth and four other insurers to testify on coverage affordability Jan. 22. UnitedHealth shares rose 1.5% to $346.85 after Wolfe Research raised its price target to $400. The company reports 2025 earnings and 2026 guidance Jan. 27. Senators also accused UnitedHealth of withholding documents in a nursing home care probe.
9 January 2026
·····
UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth shares rose 1.3% to $346.11 after U.S. House lawmakers called major health insurer CEOs to testify on coverage affordability January 22. Senators Wyden and Warren accused UnitedHealth of withholding documents in a nursing-home probe, setting a January 28 deadline. TPG is in advanced talks to buy UnitedHealth’s Optum UK unit for up to £1.4 billion, Sky News reported.
8 January 2026
····
UnitedHealth stock drops after-hours as Optum UK sale talk swirls ahead of Jan. 27 earnings

UnitedHealth stock drops after-hours as Optum UK sale talk swirls ahead of Jan. 27 earnings

UnitedHealth Group shares fell 2% to $341.70 in after-hours trading Wednesday, following a late-session slide. The drop came as investors weighed a possible Optum UK sale to TPG for up to $1.89 billion and awaited the company’s Jan. 27 earnings report. Peers Cigna, CVS Health, and Elevance Health also declined. U.S. job openings hit a 14-month low, further pressuring market sentiment.
7 January 2026
··
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth shares fell over 2% to $340.44 Wednesday morning, erasing part of Tuesday’s gain. The drop followed analyst moves, with Bernstein raising its target to $444 and Evercore ISI starting coverage at $400. Investors await UnitedHealth’s Jan. 27 results and Medicare Advantage rate updates. Humana and Cigna also declined.
7 January 2026
·······
UnitedHealth (UNH) stock gains as TPG nears Optum UK deal report, analysts lift targets ahead of earnings

UnitedHealth (UNH) stock gains as TPG nears Optum UK deal report, analysts lift targets ahead of earnings

UnitedHealth Group shares rose 2% to $348.97 Tuesday after Sky News reported TPG is nearing a deal to buy the insurer’s Optum UK unit for up to £1.4 billion. The report comes weeks before UnitedHealth’s Jan. 27 earnings, where it will give 2026 guidance. Talks remain tentative, with Bank of America advising and other firms interested. Optum UK includes EMIS, acquired for £1.24 billion and cleared by UK regulators in 2023.
7 January 2026
··
Dow Jones today: Record highs hold as investors brace for Friday jobs report

Dow Jones today: Record highs hold as investors brace for Friday jobs report

The Dow Jones Industrial Average rose 0.9% Tuesday, nearing the 50,000 mark, led by gains in UnitedHealth and Amazon. S&P 500 and Nasdaq each added about 0.5%. Traders looked ahead to Friday’s U.S. jobs report for signals on Federal Reserve rate moves. Richmond Fed President Thomas Barkin said future rate changes will depend on incoming data.
6 January 2026
·····
UnitedHealth stock jumps on TPG-Optum UK deal report as Jan. 27 earnings loom

UnitedHealth stock jumps on TPG-Optum UK deal report as Jan. 27 earnings loom

UnitedHealth Group shares rose 2.1% to $349.25 after reports TPG neared a deal to buy its Optum UK unit, valuing the business at up to £1.4 billion. The move boosted the Dow, with UnitedHealth and Amazon contributing 87 points to a 218-point gain. The company will report full-year 2025 results and 2026 guidance on Jan. 27. The Optum UK sale is not finalized and could still fall through.
6 January 2026
··
UnitedHealth (UNH) stock gains after Barclays target hike as Jan. 27 earnings loom

UnitedHealth (UNH) stock gains after Barclays target hike as Jan. 27 earnings loom

UnitedHealth shares rose 1.7% to $342.02 Monday after Barclays raised its price target to $391 and reaffirmed an Overweight rating. The move came as investors positioned ahead of UnitedHealth’s Jan. 27 earnings and 2026 guidance. The stock traded between $333.86 and $346.83 on volume of 7.9 million shares. UnitedHealth remains well below its 52-week high of $606.36.
6 January 2026
··
UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth shares rose 0.8% to $338.94 in late-morning trading Monday after Barclays raised its price target to $391 and reiterated an Overweight rating. Investors are watching ahead of Jan. 27, when UnitedHealth will report 2025 results and 2026 guidance. Scrutiny remains on medical-cost trends, operational review progress, and ongoing Justice Department investigations into Medicare Advantage billing.
5 January 2026
·····
UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results

UnitedHealth Group shares rose 1.9% to $336.40 Friday, trading 6.9 million shares and closing above key moving averages. The company will report full-year results and its 2026 outlook before the market opens Jan. 27. UnitedHealth remains under Justice Department investigation over billing practices. The stock is well below its 52-week high of $606.36.
5 January 2026
····
Dow Jones today: Boeing, Caterpillar power blue-chip rise as jobs report looms

Dow Jones today: Boeing, Caterpillar power blue-chip rise as jobs report looms

The Dow Jones Industrial Average rose 319.10 points, or 0.7%, to 48,382.39 on Friday, while the S&P 500 gained 0.2% and the Nasdaq slipped 0.03%. Industrials led the Dow’s advance, with Caterpillar and Boeing together accounting for over 200 points of the rise. Chip stocks rallied, but Tesla shares fell about 2% after reporting an 8.6% drop in 2025 deliveries. President Trump delayed higher tariffs on some Chinese imports for a year.
3 January 2026
·······
UnitedHealth stock rises today as 2026 opens; UNH holds gains after hours with earnings ahead

UnitedHealth stock rises today as 2026 opens; UNH holds gains after hours with earnings ahead

UnitedHealth shares closed up 1.9% at $336.40 Friday and rose another 0.2% after hours. Investors await the company’s Jan. 27 report on 2025 results and 2026 guidance, including updates on operational reviews and diagnosis code audits. Managed-care stocks broadly gained as the Dow rose 0.66% on the year’s first trading day. UnitedHealth continues to cooperate with federal probes into its Medicare Advantage billing practices.
3 January 2026
··
1 … 4 5 6 7 8 … 10

Stock Market Today

  • Leverage Shares to List SpaceX 3x Leverage ETP on London Stock Exchange
    June 10, 2026, 8:44 PM EDT. Leverage Shares will list its SpaceX 3x Leverage Exchange Traded Product (ETP) on the London Stock Exchange on June 12th, the company announced on June 11th. The ETP offers investors the ability to gain triple leveraged exposure to SpaceX shares, allowing for amplified returns relative to the underlying stock's daily performance. This listing adds to the growing range of leveraged products available on the LSE, catering to investors seeking enhanced market participation.

Latest articles

Tech stocks slide after hours, Oracle’s AI spending draws focus

Tech stocks slide after hours, Oracle’s AI spending draws focus

11 June 2026
Semiconductor stocks plunged 3.6%, dragging the S&P 500 technology sector into correction territory—down 11% from its June 2 record—as investors punished AI-linked companies like Oracle and Super Micro Computer for heavy spending and capital raises, signaling a shift in risk appetite amid rising inflation and escalating U.S.-Iran tensions.
Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

11 June 2026
Murphy USA soared 10.04% to $612.16 as investors seized on Casey’s General Stores’ stronger-than-expected fuel margins, spotlighting sector-wide pump profitability; with Murphy’s own first-quarter fuel contribution up 40.6% and margins at 35.0 cents per gallon, the stock’s jump reflects bets that high margins will persist, though volatility in fuel prices remains a key risk.
Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

11 June 2026
Sky Quarry soared 22.44% to $1.91 on record volume, then jumped to $2.38 after hours, as investors bet on a June refinery restart after repairs and a feedstock shortage crushed Q1 revenue to $383; with just $66,828 in cash and “substantial doubt” about its ability to continue, the stock’s fate hinges on hitting its June production target.
Go toTop